TMDX TransMedics Group

• $1.1M bought by 2 insiders
• $2.9M sold by 4 insiders outside a trading plan
• $540K sold by 1 insider under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. David Weill Director
   Buy
   $109K 1,336 shares at $81.63 +8.9% to stake
   Traded Sep 11 Filed Sep 14
   ↗
3. Stephanie Lovell Director
   Sale
   $178K 1,193 shares at $149.62 29% of stake
   Traded Mar 4 Filed Mar 6
   ↗
4. David Weill Director
   Sale
   $524K 3,571 shares at $146.82 23% of stake
   Traded Mar 4 Filed Mar 6
   ↗
5. Gerardo Hernandez CFO
   Sale
   $1.1M 7,236 shares at $147.21 33% of stake
   Traded Mar 4 Filed Mar 4
   ↗
6. David Weill Director
   Sale
   $693K 5,000 shares at $138.64 29% of stake
   Traded Dec 3, 2025 Filed Dec 5, 2025
   ↗
7. Anil P. Ranganath See remarks
   Sale
   $436K 3,000 shares at $145.22 18% of stake
   Traded Nov 25, 2025 Filed Nov 26, 2025
   ↗
8. Waleed H Hassanein CEO
   Buy
   $1M 8,775 shares at $114.00 +1.8% to stake
   Traded Nov 17, 2025 Filed Nov 18, 2025
   ↗
9. Edward M Basile Director
   Planned sale
   $540K 4,142 shares at $130.45 59% of stake
   Traded Oct 29, 2025 Filed Oct 31, 2025
   ↗

Also filed in the last 12 months, not counted as buying or selling: 12 stock grants, 7 option exercises, 5 sales to cover taxes, 1 share withholding for taxes, and 1 gift.